Social Media Content Creators Driving Unofficial Trade for Unlicensed Slimming Drug
A shadow market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share comparison images, administration instructions and assertions of next-day British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.
Service Response and Content Elimination
Based on TikTok, the platform has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Research also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, positive reviews and detailed guides for mixing or administering at home.
After moments of entering one community, a vendor shared contact information, where the majority of purchases take place. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.
Item Information and Pricing
Within these groups, messages show dark colored parcels with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering substances they can’t verify. Although the research behind retatrutide is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her team has already encountered individuals injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to potentially serious health risks”.
